Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01461382 · ClinicalTrials.gov registry record · NA
Workplace Intervention: Activity Monitoring as a Tool for Corporate Wellness and Weight Loss
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT01461382: Completed NA study, sponsored by Mayo Clinic.
NCT01461382 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01461382, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
Is a one-year intervention with Treadmill Desks associated with increased employee daily physical activity and decreased sedentariness. 36 employees with sedentary jobs (87 + 27 kg, BMI 29 + 7 kg/m2) used a Treadmill Desk for one year. Daily Physical Activity, work performance, body composition, and blood variables were measured at Baseline and 6 and 12 months after the Treadmill Desk intervention.
Primary Outcome
Measured for all waking hours using tri-axial accelerometry.
Interventions
- OTHER Treadmill Desks
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2008-05 |
| Est. Completion | 2009-12 |
| Phase | NA |
What the finished NCT01461382 record still lists
NCT01461382 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Treadmill Desks is the first listed.
NCT01461382 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01461382 about?
NCT01461382 is a clinical study titled "Workplace Intervention: Activity Monitoring as a Tool for Corporate Wellness and Weight Loss". Is a one-year intervention with Treadmill Desks associated with increased employee daily physical activity and decreased sedentariness. 36 employees with sedentary jobs (87 + 27 kg, BMI 29 + 7 kg/m2) used a Treadmill Desk for one year. Daily Physical Activity, work performance, body composition, an...
What is the current status of trial NCT01461382?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2008-05. Estimated completion is 2009-12.
What interventions are being tested in trial NCT01461382?
The interventions under investigation include: Treadmill Desks (OTHER).
Who is sponsoring clinical trial NCT01461382?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01461382's enrollment target sits among peer trials
36 1541st of 2000 higher than 437 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia